2022
DOI: 10.37796/2211-8039.1242
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Heparin Concentration on Results of Venous Blood Gas of Patients admitted to Cardiac Intensive Care Unit: A double-blind clinical Trial

Abstract: Background The aim of the present study was to investigate the effect of heparin (1000 IU/mL) in the blood sample on the results of venous blood gases of patients admitted to the cardiac intensive care unit. Materials and methods The present double-blind randomized clinical trial study was performed on 282 samples from 141 patients admitted to the cardiac intensive care unit. Insulin syringes with heparin (1000 IU/mL) and heparin (5000 IU/mL) and 1 cc of blood sample we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…However, the natural ability of blood to coagulate in response to injuries or once removed from the body creates a challenge for researchers looking to effectively replicate blood in laboratory-based experiments. To overcome this challenge, many non-forensic researchers utilize blood that has been treated with an anti-coagulant such as EDTA, citrate, and/or heparin [4][5][6][7][8][9] to aid their experimental methodology. By adding the anti-coagulant, changes are made to the whole blood and thus the study subject, in order to prevent the premature clotting [10].…”
Section: Introductionmentioning
confidence: 99%
“…However, the natural ability of blood to coagulate in response to injuries or once removed from the body creates a challenge for researchers looking to effectively replicate blood in laboratory-based experiments. To overcome this challenge, many non-forensic researchers utilize blood that has been treated with an anti-coagulant such as EDTA, citrate, and/or heparin [4][5][6][7][8][9] to aid their experimental methodology. By adding the anti-coagulant, changes are made to the whole blood and thus the study subject, in order to prevent the premature clotting [10].…”
Section: Introductionmentioning
confidence: 99%